CORT
Corcept Therapeutics Incorporated
NASDAQ: CORT · HEALTHCARE · BIOTECHNOLOGY
$46.59
-0.06% today
Updated 2026-04-29
Market cap
$5.00B
P/E ratio
56.82
P/S ratio
6.57x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$29 – $91
Volume
1.8M
Corcept Therapeutics Incorporated (CORT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
13.10%
Operating margin
2.22%
ROE
15.00%
ROA
3.34%
Debt/equity
0.01x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $294000.00 | $-24.87M | 100.00% | -8,701.36% | -8,460.20% |
| 2007 | $482000.00 | $-11.57M | 100.00% | -2,540.46% | -2,401.04% |
| 2008 | $209000.00 | $-20.06M | 100.00% | -9,420.57% | -9,598.56% |
| 2009 | $29000.00 | $-20.17M | 100.00% | -69,827.59% | -69,537.93% |
| 2010 | — | $-25.97M | — | — | — |
| 2011 | $0.00 | $-32.35M | — | — | — |
| 2012 | $3.31M | $-38.05M | 97.25% | -1,096.82% | -1,150.53% |
| 2013 | $10.36M | $-46.01M | 98.62% | -400.66% | -444.25% |
| 2014 | $26.55M | $-31.38M | 96.68% | -104.02% | -118.20% |
| 2015 | $50.29M | $-6.41M | 97.29% | -6.85% | -12.74% |
| 2016 | $81.32M | $8.14M | 97.47% | 12.52% | 10.01% |
| 2017 | $159.20M | $129.12M | 97.77% | 33.20% | 81.11% |
| 2018 | $251.25M | $75.41M | 97.92% | 35.62% | 30.01% |
| 2019 | $306.49M | $94.18M | 98.20% | 36.41% | 30.73% |
| 2020 | $353.87M | $106.01M | 98.42% | 36.23% | 29.96% |
| 2021 | $365.98M | $112.51M | 98.56% | 34.01% | 30.74% |
| 2022 | $401.86M | $101.42M | 98.66% | 28.03% | 25.24% |
| 2023 | $482.38M | $106.14M | 98.66% | 22.24% | 22.00% |
| 2024 | $675.04M | $139.73M | 98.39% | 20.29% | 20.70% |
| 2025 | $761.41M | $99.65M | 98.30% | 5.88% | 13.09% |